Immunology and infectious disease
At Abcam, we have a passion for immunology and infectious diseases and are relentless in our focus to provide new reagents to support your research discovery.
Immunology| Infectious diseases | Autoimmunity | COVID-19
Immunology
Immunology is the study of the immune system, which comprises a complex network of interacting organs, tissues, cells, and proteins that distinguishes self from non-self to defend the body against a range of internal and external threats.
We work closely with our network of immunology opinion leaders to continuously identify and develop best-in-class reagents, ranging from established pathways to newly emerging targets for rare conditions. Our recombinant antibodies offer the highest level of consistency between batches so you can achieve the reproducible results your research demands.
Our offering includes an extensive range of reagents for flow cytometry, complemented by various dyes and conjugation kits. To maximize flexibility, many of our antibodies are carrier-free, lacking BSA, glycerol, and azide for easy conjugation.
Infectious diseases
In an increasingly connected world, infectious diseases are a rapidly growing threat to human health.
We provide an extensive range of reagents that enable you to effectively study infectious diseases, and drive the development of novel diagnostics, therapeutics, and vaccines. Sensitive, specific, and reliable reagents are crucial to the development of countermeasures to infectious diseases.
That's why we work closely with our network of collaborators to validate antibodies in disease-relevant samples to show minimal-to-no cross-reactivity in applications such as ELISA, ICC, and IHC. Our offering covers a diverse range of viral, bacterial, fungal, and protozoal pathogens, including both endemic and emerging diseases.
Autoimmunity
Autoimmune diseases affect more and more people every year, including conditions such as rheumatoid arthritis, inflammatory bowel diseases, and lupus.
To address the increasing burden of autoimmune conditions and the need for effective treatments, we are continuously developing our portfolio of best-in-class autoimmune reagents.
With a broad spectrum of heterogeneous and poorly defined conditions, specific, sensitive, and batch-specific reagents and assays are crucial to making breakthroughs. Working closely with our academic and industry collaborators, we offer various unique reagents for both human and animal targets.
You’ll find recombinant antibodies, bioactive cytokines, and 90-minute SimpleStep ELISAs® validated for a range of applications, such as ELISA, Western blot, IHC, flow cytometry, ICC, and IP.
See our high-quality reagents for autoimmunity
COVID-19
In 2019, SARS-CoV-2 emerged and spread rapidly around the globe, leading to economic shutdowns and an ongoing health crisis. Since the development and rollout of vaccines, population immunity has increased to safer levels. However, with the accelerating emergence of new variants and the growing burden of long COVID, significant research is still needed. In response, we’ve developed over 100 proteins, antibodies, and ELISAs for SARS-CoV-2 research and the development of diagnostics, therapeutics, and vaccines.
We are also continuing to develop reagents for emerging variants and the validation of countermeasures against them.
Explore our solutions for coronavirus R&D
Interested in working together to further immunology and infectious disease research?
We collaborate with researchers around the world to develop our leading reagents pipeline.
Contact us at immunology@abcam.com